- Children aged 6 months to < 18 years with confirmed venous thromboembolism who receive initial treatment with therapeutic dosages of UFH (unfractionated Heparin), LMWH (low molecular weight heparin) or fondaparinux and require anticoagulant therapy for at least 90 days